Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 22% ± 7% | |
glutamatergic neuron | 5 studies | 35% ± 22% | |
oligodendrocyte precursor cell | 4 studies | 24% ± 6% | |
neuron | 3 studies | 27% ± 3% | |
GABAergic neuron | 3 studies | 39% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 12476.40 | 2638 / 2642 | 100% | 54.75 | 703 / 705 |
adrenal gland | 62% | 898.59 | 161 / 258 | 91% | 34.56 | 209 / 230 |
prostate | 59% | 798.74 | 145 / 245 | 54% | 4.11 | 273 / 502 |
ovary | 20% | 250.49 | 36 / 180 | 70% | 6.54 | 303 / 430 |
uterus | 52% | 728.56 | 88 / 170 | 34% | 4.73 | 158 / 459 |
skin | 0% | 1.36 | 2 / 1809 | 76% | 13.62 | 361 / 472 |
intestine | 53% | 804.27 | 515 / 966 | 20% | 1.07 | 103 / 527 |
esophagus | 49% | 707.71 | 704 / 1445 | 24% | 1.76 | 44 / 183 |
breast | 6% | 66.10 | 26 / 459 | 64% | 5.58 | 717 / 1118 |
pancreas | 0% | 2.86 | 1 / 328 | 62% | 4.42 | 110 / 178 |
bladder | 38% | 455.14 | 8 / 21 | 23% | 2.06 | 115 / 504 |
stomach | 23% | 337.87 | 83 / 359 | 22% | 1.17 | 62 / 286 |
lung | 0% | 3.75 | 2 / 578 | 41% | 2.98 | 473 / 1155 |
blood vessel | 35% | 463.60 | 463 / 1335 | 0% | 0 | 0 / 0 |
heart | 34% | 452.94 | 295 / 861 | 0% | 0 | 0 / 0 |
thymus | 1% | 15.12 | 6 / 653 | 32% | 2.55 | 191 / 605 |
kidney | 2% | 26.10 | 2 / 89 | 29% | 2.58 | 260 / 901 |
eye | 0% | 0 | 0 / 0 | 28% | 1.64 | 22 / 80 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.00 | 6 / 29 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.77 | 6 / 45 |
liver | 0% | 0 | 0 / 226 | 12% | 0.58 | 49 / 406 |
adipose | 0% | 1.68 | 2 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_2000807 | Biological process | regulation of synaptic vesicle clustering |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0007269 | Biological process | neurotransmitter secretion |
GO_0051298 | Biological process | centrosome duplication |
GO_0006974 | Biological process | DNA damage response |
GO_0008306 | Biological process | associative learning |
GO_0009411 | Biological process | response to UV |
GO_0007409 | Biological process | axonogenesis |
GO_0090176 | Biological process | microtubule cytoskeleton organization involved in establishment of planar polarity |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0030182 | Biological process | neuron differentiation |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0099504 | Biological process | synaptic vesicle cycle |
GO_0010975 | Biological process | regulation of neuron projection development |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0006468 | Biological process | protein phosphorylation |
GO_0050770 | Biological process | regulation of axonogenesis |
GO_0150034 | Cellular component | distal axon |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0048786 | Cellular component | presynaptic active zone |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0030054 | Cellular component | cell junction |
GO_0005634 | Cellular component | nucleus |
GO_0043015 | Molecular function | gamma-tubulin binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0048156 | Molecular function | tau protein binding |
Gene name | BRSK1 |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) BR serine/threonine kinase 1 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) |
Synonyms | SAD1 KIAA1811 SADB |
Description | FUNCTION: Serine/threonine-protein kinase that plays a key role in polarization of neurons and centrosome duplication. Phosphorylates CDC25B, CDC25C, MAPT/TAU, RIMS1, TUBG1, TUBG2 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. In neurons, localizes to synaptic vesicles and plays a role in neurotransmitter release, possibly by phosphorylating RIMS1. Also acts as a positive regulator of centrosome duplication by mediating phosphorylation of gamma-tubulin (TUBG1 and TUBG2) at 'Ser-131', leading to translocation of gamma-tubulin and its associated proteins to the centrosome. Involved in the UV-induced DNA damage checkpoint response, probably by inhibiting CDK1 activity through phosphorylation and activation of WEE1, and inhibition of CDC25B and CDC25C. . |
Accessions | ENST00000592539.6 K7EM68 ENST00000590333.5 [Q8TDC3-2] ENST00000591774.5 ENST00000309383.6 [Q8TDC3-1] Q8TDC3 ENST00000326848.7 K7EN26 ENST00000585418.1 [Q8TDC3-3] J3KNK0 |